Percutaneous Coronary Intervention With Bioresorbable Scaffolds in a Young Child

Tamim M Nazif1, Sanjog Kalra2, Ziad A Ali1

  • 1Division of Cardiology, Columbia University Medical Center, New York, New York2Cardiovascular Research Foundation, New York, New York.

JAMA Cardiology
|December 29, 2016
PubMed

Insights

This case report details the first use of a bioresorbable scaffold (BRS) in a child with severe coronary artery disease. The procedure was successful, showing potential for BRS in pediatric cardiovascular interventions.

Area of Science:

  • Pediatric Cardiology
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Coronary artery disease (CAD) requiring revascularization is rare in children but can occur due to conditions like homozygous familial hypercholesterolemia.
  • Conventional metallic stents have limitations in pediatric patients, necessitating exploration of alternative treatments.
  • Bioresorbable scaffolds (BRS) offer potential advantages over metallic stents in pediatric coronary interventions.

Observation:

  • A 3-year-old boy with homozygous familial hypercholesterolemia presented with unstable, multivessel coronary artery disease.
  • Intravascular imaging-guided PCI was performed using BRS in the right coronary artery, left main, and left circumflex arteries.

Findings:

  • The PCI procedure using BRS achieved acute procedural success.
  • Postmortem histological assessment revealed patent BRS with nonobstructive neointimal hyperplasia, indicating successful scaffold integration and function.

Implications:

  • This case represents the first documented use of BRS in a pediatric patient for coronary artery disease.
  • Bioresorbable scaffolds show promise for the future treatment of pediatric coronary artery disease, warranting further investigation.
Abstract

Related Concept Videos